The bacterial endosymbiont Wolbachia is a biocontrol tool that inhibits the ability of the Aedes 12 aegypti mosquito to transmit positive-sense RNA viruses such as dengue and Zika. Growing 13 evidence indicates that when Wolbachia strains wMel or wAlbB are introduced into local 14 mosquito populations, human dengue incidence is reduced. Despite the success of this novel 15 intervention, we still do not fully understand how Wolbachia protects mosquitoes from viral 16 infection. Here, we demonstrate that the Wolbachia strain wPip does not inhibit virus infection 17 in Ae. aegypti. We have leveraged this novel finding, and a panel of Ae. aegypti lines carrying 18 virus-inhibitory (wMel and wAlbB) and non-inhibitory (wPip) strains in a common genetic 19 background, to rigorously test a number of hypotheses about the mechanism of Wolbachia-20 mediated virus inhibition. We demonstrate that, contrary to previous suggestions, there is no 21 association between a strain's ability to inhibit dengue infection in the mosquito and either its 22 typical density in the midgut or salivary glands, or the degree to which it elevates innate 23 immune response pathways in the mosquito. These findings, and the experimental platform 24 provided by this panel of genetically comparable mosquito lines, clear the way for future 25 investigations to define how Wolbachia prevents Ae. aegypti from transmitting viruses. 26 enable us to predict the risk of viral resistance arising against Wolbachia and facilitate 39 preparation of second-generation field release lines. 40
Author summary 27
Dengue virus, transmitted by the Aedes aegypti mosquito, is one of the fastest-growing 28 infectious diseases, causing an estimated 390 million human infections per year worldwide. 29
Vaccines have limited efficacy and there are no approved therapeutics. This has driven the 30 rise of novel vector control programs, in particular those that use the bacterium, Wolbachia, 31 which prevents transmission of dengue and other human pathogenic viruses when stably 32 introduced into Ae. aegypti populations. Although this is proving to be a highly effective 33 method, the details of how this biocontrol tool works are not well understood. Here we 34 characterise a new Wolbachia strain, wPip, and find that Ae. aegypti carrying wPip are still 35 able to transmit dengue similar to mosquitoes that do not carry Wolbachia. This finding has 36 allowed us to begin a rigorous program of comparative studies to determine which features of 37 a Wolbachia strain determine whether it is antiviral. Understanding these mechanisms will 38
Introduction 42
The Aedes aegypti mosquito is the primary vector for many human pathogenic viruses 43 including dengue (DENV), Zika (ZIKV) and chikungunya (CHIKV). Global incidence of 44 arthropod-borne viruses (arboviruses) such as these is increasing in response to urbanization in 45 the tropics, as well as globalization and expansion of the geographical range of Ae. aegypti [1, 46 2] . Arboviruses like DENV are typically associated with acute, self-limiting febrile disease, 47 although severe manifestations can occur, in some instances leading to death. There are 48 currently no approved specific antiviral therapeutics for DENV, ZIKV or CHIKV and recently 49 developed vaccines for DENV are suboptimal and controversial [3] [4] [5] [6] . As such, treatment is 50 supportive only and limiting virus transmission is largely dependent on vector control. 51
We and others have produced and characterized a series of Ae. aegypti lines transinfected with 77 different Wolbachia strains (summarized in So far, all 7 of the Wolbachia-carrying Ae. aegypti lines tested have provided some level of 83 protection against flaviviruses. Here, we characterize the vector competence of Ae. aegypti 84 transinfected with wPip (from Culex quinquefasciatus, supergroup B). Past data has suggested 85 that removal of wPip from its natural host by antibiotic treatment leads to an increase in the 86 replication of DENV-related flavivirus West Nile virus (WNV), indicating that wPip may be 87 antiviral in this context [32] . We previously reported the generation of a wPip-Ae. aegypti line 88 [26] , and that wPip resides at a high density in Ae. aegypti -a feature widely regarded as 89 important for Wolbachia to impart its antiviral effects [33] [34] [35] . However, we show here that 90 wPip does not restrict flavivirus replication, dissemination or reduce the transmission potential 91 in Ae. aegypti. We leverage this finding to understand more about what makes a Wolbachia 92 strain antiviral. We compare the density and tissue specificity of wPip and antiviral strains 93 wMel and wAlbB, in Ae. aegypti backcrossed onto the common laboratory Rockefeller Ae. 94 aegypti line and identify no link between strains that reside at high density in the midgut or 95 salivary glands, and those that protect against DENV. Furthermore, we determine that 96 commonly used proxies of immune activation of the host are not induced by all antiviral 97 Briefly, 60 seven-day old females were injected with 6.3 x 10 5 TCID50/ml of DENV-3, or a 111 10-fold dilution thereof. Total RNA was extracted from whole, surviving mosquitoes 7 days 112 post infection. Absolute DENV-3 RNA copies were determined in each mosquito by PCR and extrapolation to a standard curve. Consistent with previous reports, wMel restricted 114 DENV replication by approximately 1log10 compared to its matched Tet control line, when 115 injected with either concentration of virus ( Fig. 1A and B ) [26, 36] . Notably, 37 of 49 116 injected wMel mosquitoes scored positive for DENV-3 infection (>1000 copies/mosquito) 117 when injected with 6.3 x 10 5 TCID50/ml, compared to just 15 of 47 wMel mosquitoes when 118 injected with 6.3 x 10 4 TCID50/ml ( Fig. 1A respective Tet control lines were fed a blood meal containing freshly harvested cell culture-145 derived DENV-3 (6.6 x 10 6 TCID50/mL diluted 1:1 in sheep blood). Mosquitoes were 146 incubated for 15 days, then the body and head of the mosquito were collected separately as 147 indicators of established infection and viral dissemination, respectively. No wMel-carrying 148 mosquitoes that took a blood meal established a DENV-3 infection, compared to 74% of the 149 matched Tet control cohort, and a >4log10 reduction in mean DENV-3 copies/body were 150 observed in the presence of wMel ( Fig. 2 and Table 2 ). By contrast, 93% of wPip-151 transinfected mosquito bodies scored positive for DENV-3, similar to 96% of the matched 152 Tet control cohort, with a slight, although significant, decrease in the mean viral 153 copies/mosquito in wPip-carrying mosquitoes compared to its matched Tet control cohort. No 154 wMel mosquitoes had viral RNA disseminated to their heads, compared to 75% of wMel.Tet 155 mosquitoes. Similar numbers of wPip-and wPip.Tet-carrying mosquitoes scored positive for 156 disseminated infection (83% and 97%, respectively), and the mean DENV copies/head was 157 slightly but significantly greater in wPip-infected mosquitoes compared to wPip.Tet. Note 158 that the slight increases and decreases in viral copy number observed for wPip-carrying 159 mosquitoes compared to the Tet control line are likely to be due to biological variability, as 160 they were not consistent across 3 independent experiments. The overall trend clearly showed 161 no difference between the vector competence of these two lines. 162
We further examined the saliva from a proportion of mosquitoes that were fed a virus-spiked 163 blood meal to determine whether infectious virus could be transmitted by wPip-carrying 164 mosquitoes. Saliva was collected from ~15 mosquitoes/line (donor mosquitoes) at 15-days 165 post-infection. Each saliva sample was then injected into the thorax of 6 wMel.Tet recipient 166 mosquitoes to assess the replication competence of the virus. Seven days later, injected 167 mosquitoes were harvested, total RNA was extracted and qRT-PCR performed to determine 168 the number of recipients positive for virus infection (>10 3 DENV copies/mosquito). wMel 169 caused a significant reduction in the number of donor mosquitoes that carried infectious 170 DENV in their saliva, compared to its matched Tet control line (Fisher's exact test p<0.05), 171 but wPip did not ( Fig. 2B and Table 2 
Differences in mosquito host genetics do not underlie wPip's lack of antiviral activity. 180
Following microinjection of a new Wolbachia strain into Ae. aegypti, an intense genetic 181 bottlenecking occurs as we select individual mosquitoes that carry Wolbachia. To determine 182 whether the lack of antiviral activity observed for wPip was due to specific genetic features of 183 the host mosquito selected during this process, we backcrossed our Wolbachia-carrying lines 184 to the inbred laboratory mosquito line, Rockefeller, through six generations, placing each 185
Wolbachia strain into the same nuclear genetic background. Intrathoracic injection of these 186 lines with DENV-2 confirmed a lack of viral restriction by wPip (Supp Fig. 1 Our novel identification of a Wolbachia strain that does not appear to restrict flaviviruses in 193
Ae. aegypti, generated an opportunity to determine what features of Wolbachia are common 194 to antiviral strains. Several reports have suggested that the ability of a Wolbachia strain to 195 inhibit viruses is dependent on the density at which it resides in its host [33] [34] [35] . Our previous 196 work demonstrated that wPip resides at a comparable density to wMel in whole Ae. aegypti 197 mosquitoes [26] . However, it is not known whether these strains reside differentially within 198 specific tissues that may explain the disparity in their antiviral activity. To test this rigorously 199 we used our Rockefeller Ae. aegypti lines carrying the antiviral Wolbachia strains wMel or 200 wAlbB (classified as Wolbachia supergroup A and B strains, respectively), or wPip (from 201 supergroup B), to compare the densities of Wolbachia in the salivary glands and midguts of 202 female mosquitoes/line, 6-7 days post emergence. Wolbachia density was determined by 203 amplifying the conserved Wolbachia 16S rRNA gene and normalising this to the Ae. aegypti 204 host rps17 gene. All 3 Wolbachia strains were found to reside at similar densities in whole 205 mosquitoes (between 10 and 14 Wolbachia per host cell, Fig. 3A ). Given that mosquito 206 salivary glands must become infected with virus in order for the mosquito to transmit DENV, 207 we hypothesized that this tissue would be highly colonized by antiviral Wolbachia strains. 208 Surprisingly, the mean relative wMel density was shown to be very low (1 Wolbachia per 209 host cell), while wAlbB and wPip resided at substantially and significantly higher mean 210 levels (11 and 13 Wolbachia per host cell; p<0.0001 Kruskal-Wallis test). Given this 211 unexpected finding, we next examined whether the tissues surrounding the salivary glands 212 may be contributing high Wolbachia densities to mediate the antiviral phenotype observed 213 for wMel-carrying mosquitoes. To do this we separated the head/thorax from the abdomen of 214 mosquitoes and determined the Wolbachia density. The densities of wMel, wAlbB and wPip 215 in the head/thorax closely reflected what was observed in salivary glands alone. It therefore 216 appears that high levels of Wolbachia are not required in or around the salivary glands in 217 order to provide an antiviral phenotype. Similarly, the findings for wPip demonstrate that 218 high levels of Wolbachia can reside in this critical tissue and not impact virus inhibition. 219
We next used confocal laser scanning microscopy to examine whether wPip localises 220 differently within the salivary gland tissue, to enable DENV replication. Salivary glands were 221 dissected from female mosquitoes 6 days post emergence and stained by fluorescence in situ 222 hybridization (FISH) using probes that detect the conserved Wolbachia rRNA gene 16S [11] 223 and DAPI to demarcate the salivary gland tissue. Slides were imaged as 3-dimensional z-224 stacks and 2D images were generated by Maximum Intensity Projection (MIP) using Fiji 225 software. As expected, there was negligible staining observed in the Rockefeller control 226 samples indicating the specificity of the FISH probes ( Fig. 3B ). wPip localized similarly to 227 the antiviral strain wAlbB, at high levels, but quite diffusely throughout the three lobes of the 228 salivary glands. Consistent with the lower levels of wMel measured by qPCR, this Wolbachia 229 strain appeared less prevalent, although interestingly, it was observed to localize in one 230 clustered location of a single lobe. Together, these results show that antiviral Wolbachia 231 strains can localise differently within the salivary glands, and that high levels of Wolbachia 232 are not required in this tissue to prevent DENV transmission. 233
We next examined the density of these Wolbachia strains in the midgut of the mosquito (the 234 site of virus adsorption and internalization following an infectious blood meal). Interestingly, 235
wMel was present at very low mean levels in the midgut (0.1 Wolbachia per host cell). wPip 236 mean levels were approximately 6 times that of wMel (0.6 Wolbachia per host cell), while 237 wAlbB resided at the highest density (mean 2.5 Wolbachia per host cell; Fig. 3A ). 238
To examine whether tissues surrounding the midgut contain high levels of wMel that may 239 explain limited DENV replication in the body of these mosquitoes, we measured the density 240 of each Wolbachia strain in mosquito abdomens. Ovaries were removed from the dissected 241 abdomens prior to DNA extraction to prevent obscuring by the high levels of wMel in this 242 tissue [37] . While the Wolbachia densities were substantially higher for all lines compared to 243 the midgut alone, the trend across the three lines was almost identical with wMel residing at 244 the lowest density, then wPip, with wAlbB residing at the highest density. Thus, the tissues 245 immediately surrounding the midgut are not supporting high levels of wMel to supplement 246 the lower Wolbachia densities observed in this tissue. 247
These findings indicate that a strict localization and density profile at the tissue level is not 248 linked to the antiviral phenotype of Wolbachia strains. This conclusion is supported by the 249 recent publication by Flores et al. (submitted, PloS Path.) who determined that wMel inhibits 250 DENV replication in mosquito abdomens better than wAlbB, despite wAlbB residing at 251 higher density than wMel in the midgut and salivary glands as shown here. 252
Of note, wAlbB and wPip (both belonging to supergroup B and therefore more closely related 253 to each other than to wMel) seem to display similar tissue distribution and densities in all the 254 tissues examined here, while the profile of wMel is quite different. 255 256 Wolbachia-mediated antiviral protection is not dependent on elevated innate immune 257 response pathways in Ae. aegypti. 258
We next tested the hypothesis that Wolbachia infection in Ae. aegypti elevates expression of 259 several innate immune pathway components, particularly in novel Wolbachia-host 260 associations, to create an antiviral environment [11, [21] [22] [23] . To do this we used our panel of 261 genetically comparable Rockefeller Ae. aegypti-Wolbachia lines, with the addition of 262 wMelPop (also in the Rockefeller background) -a strongly antiviral Wolbachia strain that 263 enhances expression of innate immune pathway components in Ae. aegypti [11, [21] [22] [23] . We 264 assessed the expression levels of Toll pathway components (cecropin D, cecropin E, defensin 265 C), known to control anti-DENV defences in mosquitoes [38] , and previously reported to be 266 upregulated by some Wolbachia strains in Ae. aegypti [11, [21] [22] [23] . We also assessed 267 expression levels of C-type lectin (immune recognition molecule) and transferrin (regulation 268 of oxidative stress through iron sequestration), other proteins involved in innate immunity 269 and previously reported to be upregulated by some Wolbachia strains in Ae. aegypti [11, 21, 270 23] . 271
Twenty-four female mosquitoes carrying wMel, wAlbB, wPip, wMelPop, or Rockefeller (no 272 Wolbachia control) were collected 6-days post-emergence. Whole mosquito RNA extracts 273 from each individual were converted to cDNA, then expression levels of immune molecules 274 were measured by qPCR, and quantified relative to the mosquito gene rps17. Mosquitoes 275 carrying wMelPop had significantly elevated levels of each of these representative pathway 276 components compared to the Rockefeller control (Kruskal-Wallis test, Fig. 4 ). The 277 magnitude of expression increase varied between the transcripts examined, with the smallest 278 increase observed for C-type lectin (10-fold increase) and the largest observed for defensin C 279 (~250-fold). In contrast, only very small or no increase in expression of these components 280 was observed in Ae. aegypti carrying wMel, wAlbB or wPip, relative to the Rockefeller 281 control. wMel did significantly increase expression of cecropin E and defensin C, but these 282 increases were very small in comparison to wMelPop (6-and 2.5-fold increases in the 283 presence of wMel, compared to 180-and 270-fold increases in the presence of wMelPop) and 284
were not observed in the other antiviral strain, wAlbB. This is the first time Wolbachia-285 induced immune gene expression has been examined in genetically comparable Ae. aegypti 286 lines, using a variety of Wolbachia strains that either inhibit or do not inhibit DENV. Using 287 this rigorous approach, we can state that elevated expression of these immune components is 288 not consistently associated with a Wolbachia-mediated antiviral phenotype in Ae. aegypti. 289
290

Discussion 291
Dissecting the molecular mechanisms that underpin the inhibition of human pathogenic viruses 292 by various Wolbachia strains will facilitate the continued success and longevity of Wolbachia-293 based biocontrol programs. This will provide a means to screen for the possible emergence of 294 viral resistance prior to detecting an increase in human disease in Ae. aegypti-Wolbachia 295 established areas. In addition, it will allow us to identify second-generation Wolbachia strains 296 that may restrict viruses using different mechanisms. 297
wPip is the first Wolbachia strain that has been introduced into Ae. aegypti without providing 298 antiviral protection towards flaviviruses. A recent study from Ant et al., 2018, introduced 299 wAlbA from Ae. albopictus into Ae. aegypti. This line carried wAlbA at a high density yet 300 did not restrict DENV or ZIKV following intrathoracic viral injection [29] . However, when 301 vector competence was examined following an infectious blood meal (DENV or ZIKV), viral 302 infection, dissemination and transmission rates were significantly reduced [30] . We have 303 previously shown that intrathoracic injection challenges with high virus concentrations can 304 overwhelm Wolbachia-mediated inhibition [26] . This mode of infection may underestimate 305 the ability of a Wolbachia strain to inhibit arboviruses unless injections are performed using a 306 range of virus concentrations. These findings demonstrate the importance of rigorous assay 307 design for vector competence analyses. 308
Our generation of a novel panel of genetically comparable Ae. aegypti lines carrying different 309
Wolbachia strains, including one with a non-antiviral strain (wPip), has allowed us to begin 310 rigorously testing a series of hypotheses of the mechanisms underlying viral restriction by 311
Wolbachia. Until recently, it was widely accepted that inhibition of viruses in this context 312 correlated with Wolbachia density. This dogma was based on a series of experiments using 313 mosquito cell culture and Drosophila lines carrying a variety of Wolbachia strains, or titrations 314 of a single Wolbachia strain by antibiotic treatment [33] [34] [35] . However, here, we demonstrate 315 that antiviral phenotype is not dictated by the density at which it resides in either the whole 316 body, salivary glands, the midgut or the tissues immediately surrounding these in the mosquito. 317
This finding builds on, and is consistent with reports that wAlbA resides at substantially higher 318 levels than wAlbB and wMel in the midgut and the salivary glands of Ae. aegypti, despite 319
wAlbA showing a relatively limited ability to inhibit flavi-and alphavirus replication [29, 30] . 320 Amuzu and McGraw (2016) , examined this in another way, determining that the relationship 321 between DENV inhibition and wMel density within a single Ae. aegypti tissue sample is not 322 linear [39] . This finding supports our conclusion that it is not simply the amount of Wolbachia 323 present in a tissue that determines whether or not a Wolbachia strain is able to inhibit DENV. 324
If Wolbachia does not have to be present at high densities to impair viral replication, then this 325 also questions an existing hypothesis that Wolbachia impairs viral replication by competing 326 for space within host cells [11, 19, 20] . Further work is needed to analyse the subcellular 327 localisation of various Wolbachia strains to determine whether this may determine the antiviral 328 activity of a strain. 329
Several studies have implied that Wolbachia may prime the host innate immune system, 330 preventing arboviral establishment [11, [21] [22] [23] . The importance of the contribution of this 331 mechanism has been clouded by the fact that expression levels of these pathway components 332 seems to vary depending on how long the Wolbachia strain has resided in its host [21] . We 333 selected a series of immune effectors previously shown to be upregulated by wMelPop, wMel 334 or wAlbB in Ae. aegypti, relative to no-Wolbachia control lines. These included toll pathway 335 components (cecropin D, E, and defensin C), C-type lectin (immune recognition molecule), 336 and oxidative stress regulator transferrin [11, [21] [22] [23] . Using our panel of comparable 337
Wolbachia-Rockefeller mosquito lines our findings definitively show that these pathways do 338 not need to be primed at high levels by Wolbachia in order to restrict viral replication. While 339 we have not exhaustively considered all innate immune pathways, this finding is consistent 340 with observations from Rances et al., 2012 , who identified upregulation of many immune 341 genes only occurred in wMel-and wMelPop-Ae. aegypti where the endosymbiont was a 342 newly acquired infection, but not in the original D. melanogaster host where these strains are 343 similarly antiviral [21] . 344
We initially produced the wPip-Ae. aegypti line based on work in the native Culex mosquito 345 host that showed removal of wPip led to enhanced levels of WNV [32] . Given that wPip does 346 not protect against flaviviruses in Ae. aegypti, our results show that there is likely to be a 347 specific Wolbachia-host interaction that determines whether a Wolbachia strain creates an 348 antiviral state in its host. This host-dependent context has previously been seen for wAlbB: 349 this strain does not provide clear protection against flaviviruses in its native Ae. albopictus 350 host [13] , but effectively inhibits flaviviruses in Ae. aegypti [13, 29, 36] . This finding poses an interesting issue for selecting Wolbachia strains for novel Ae. aegypti 360 lines -that is, how can we predict whether a new strain will induce an antiviral state? 361
Notably, so far it seems that the magnitude of the antiviral effect of a Wolbachia strain 362 measured in Drosophila spp. predicts how the strain will behave in Ae. aegypti (from the 5 363 strains examined) [10, 11, 26, 28, 29, 43, 44 ]. This has not been the case for mosquito-364 derived Wolbachia strains -wAlbA and wAlbB are not antiviral in their native host, but do 365 provide protection in Ae. aegypti, while wPip is reported to be antiviral in Cu. 366 quinquifaciatus, but not in Ae. aegypti [13, 30, 32] . Perhaps this is due to differences in the 367 way these Wolbachia strains localise in each host. And/or, if multiple mechanisms contribute 368 to viral inhibition, perhaps each host-Wolbachia combination has some or all of these 369 mechanisms in play. 370
The introduction of other novel Wolbachia strains into Ae. aegypti is required to determine if 371 this trend holds. 372
In this study we have generated a unique and powerful tool: a panel of Ae. aegypti lines that 373 differ only in the Wolbachia strain that they carry, including wPip-Ae. aegypti which does not 374 restrict flavivirus replication, dissemination or transmission. This is an important finding as it 375 identifies a refined negative control for studies trying to understand how Wolbachia affects 376 its host. A Wolbachia-free control has been used in the past, but this control does not account 377 for the many host effects Wolbachia can induce just by residing as an endosymbiont, that 378 may not be responsible for creating an antiviral state [45, 46] 
Mosquito rearing 386
All Ae. aegypti mosquitoes were reared and maintained as described previously [26, 27, 37] . 387
Briefly, adult mosquitoes were maintained at 26°C, 65% relative humidity (RH) and a 12 h 388 light:dark cycle in a climate-controlled room. Mosquitoes were blood fed on the arms of human 389 volunteers (Monash University human ethics permit CF11/0766-2011000387). The 390
Wolbachia-infected wMel, wAlbB and wPip lines as well as matched Tet-control lines 391 (Wolbachia infected lines that have been cured of their infection by tetracycline treatment) 392 used in these experiments have been described previously [26, 28, 48] For feeding experiments with DENV-3 (Cairns 08/09) infected blood, 100 seven-day old age-408 controlled female mosquitoes were placed in 500 mL plastic containers (five containers per 409
Wolbachia line, three containers per Tet line), starved for up to 24 h and allowed to feed on a 410 50:50 mixture of defibrinated sheep blood and tissue culture supernatant containing freshly 411 harvested 6.6 x 10 6 TCID50/mL of DENV-3. Feeding was done through a piece of desalted 412 porcine intestine stretched over a water-jacketed membrane feeding apparatus preheated to 413 37°C. Mosquitoes were left to feed in the dark for approximately 1-2 hours. Fully engorged 414 mosquitoes were placed in 500 mL containers at a density of < 25/container, and incubated 415 for 15 d at 26°C with 65% RH and a 12 h light/dark cycle. 416
For adult microinjections, 60 six-or seven-day old age-controlled female mosquitoes were 417 anesthetized by CO2. Mosquitoes were injected intrathoracically with 69 nL of DENV 418 (DENV-3 Cairns 08/09 strain at 6.3 x10 5 or 6.3 x10 4 TCID50/ml, or DENV-2 Vietnam strain 419 at 2.4 x 10 5 ) in RPMI media (Life Technologies) using a pulled-glass capillary and a 420 handheld microinjector (Nanoject II, Drummond Scientific). For KUNV injections, 69 nL of 421 1.4 x10 7 or 1.4 x10 6 TCID50/ml was injected per mosquito using the same method as 422 described for DENV-3. Injected mosquitoes were incubated for 7 days (15 mosquitoes/cup) 423 at 26°C with 65% RH and a 12 h light/dark cycle. 424
To quantify DENV-3 or KUNV genomic copies, total RNA was isolated from mosquitoes 425 (entire mosquitoes for injection experiments, or head and bodies separately for blood-fed 426 mosquitoes) using the RNeasy 96 QIAcube HT kit (Qiagen). DENV-3 RNA was amplified 427 by qRT-PCR (LightCycler Multiplex RNA Virus Master, Roche), using primers to the 428 conserved 3'UTR: Forward 5'-AAGGACTAGAGGTTAGAGGAGACCC; Reverse 5'-429 CGTTCTGTGCCTGGAATGATG; Probe 5'-HEX-430 AACAGCATATTGACGCTGGGAGAGACCAGA-BHQ1-3' [52]; absolute copies were 431 determined by extrapolation from an internal standard curve generated from plasmid DNA 432 encoding the conserved 3'UTR sequence. Mosquito extracts with >1000 copies of DENV per 433 body were scored positive, based on the LOD95 (limit of detection 95%) for DENV-3 with 434 this primer set. KUNV RNA was amplified by using primers that span the 3' end of the 435 conserved NS5 gene, and the 3'UTR: Forward 5'-AACCCCAGTGGAGAAGTGGA; 436
Reverse 5'-TCAGGCTGCCACACCAAA; Probe 5'-HEX -437 CGATGTTCCATACTCTGGCAAACG -BHQ1-3' [53] . KUNV RNA copies were 438 quantified relative to Ae. aegypti house-keeping gene rps17 using the delta CT method 439
(2 CT (reference)/ 2 CT (target)). KUNV RNA copies with a CT of < 33 were scored positive for 440 infection. Note that all surviving mosquitoes were processed for virus injection experiments, 441 while a maximum of 72 mosquitoes/line were collected and processed for blood feeding 442 experiments. 443
Virus transmission 444
To determine whether Wolbachia-infected mosquitoes were capable of transmitting infectious 445 virus, 15 blood-fed mosquitoes per line were collected at 15 days post blood feed (donor 446 mosquitoes). The proboscis from each donor was inserted into a 10 µL pipette tip containing 447 10 µL 1:1 FBS:30% sucrose [54] . Legs and wings were removed to encourage the mosquitoes 448 to spit. Pipette tips were collected 1 hour later and the virus solution ejected onto parafilm. The 449 solution was drawn up into a pulled-glass capillary attached to a handheld microinjector 450 (Nanoject III, Drummond Scientific) and 600 nL was injected into 6 seven-day old recipient 451 wMel.Tet mosquitoes. Replicate recipient mosquitoes were stored in a single container for 7-452 days post injection. RNA was extracted from the whole bodies of all surviving mosquitoes, and 453 qRT-PCR was performed as described above. 454
Wolbachia density and distribution 455
Relative Wolbachia density in wMel, wAlbB and wPip was determined in whole or dissected 456 tissues from female mosquitoes at 5-days post emergence, using qPCR with primers to amplify 457 a fragment of the conserved 16S rRNA gene (forward primer: 5'-458 GAGTGAAGAAGGCCTTTGGG-3', reverse primer: 5'-459 CACGGAGTTAGCCAGGACTTC-3', probe 5' LC640-460 CTGTGAGTACCGTCATTATCTTCCTCACT-IowaBlackRQ-3') and the reference Ae. 461 aegypti rps17 gene (forward primer: 5'-TCCGTGGT ATCTCCATCAAGCT-3', reverse 462 primer:
5'-CACTTCCGGCACGTAGTTGTC-3', probe 5'FAM-463 CAGGAGGAGGAACGTGAGCGCAG-BHQ1-3') [26] . Wolbachia densities were quantified 464 relative to rps17 using the delta CT method as previously (2 CT (reference)/ 2 CT (target)). 465
Salivary gland dissections and fluorescence in-situ hybridization (FISH) staining 466
Female mosquitoes were collected 6-days post emergence, knocked down at -20°C for 2 467 minutes, then kept in a petri dish on ice until dissection. Individuals were dissected on a 468 microscope slide in a drop of PBS. Briefly, the head of the mosquito was sliced off using a 469 dissection needle, and the salivary glands popped out by gently squeezing the thorax with 470 needle-tipped forceps. Salivary glands were gently transferred to a small droplet of PBS on 471 poly-lysine-coated slides. Tissues were fixed in cold 4% paraformaldehyde in PBS for 15 472 minutes, rinsed 3 times in PBS, then permeabilised in 100% ethanol for 5 minutes and air dried. 473
Slides were incubated in hybridization buffer containing fluorescently labelled 16S rRNA 474 probes (cross-reactive with all three Wolbachia strains) [11] overnight at 37°C in a humidified 475 chamber. Slides were washed in SSC buffers + 10 mM DTT, stained with DAPI, and mounted 476 as described by Moreira et al., 2009 [11] . 477
Confocal microscopy 478
Slides were imaged using a Nikon C1 Upright confocal microscope at 20X magnification 479 (under oil) as 3-dimensional z-stacks with a step-size of 3 microns. Images were acquired 480 with NIS-Elements software. Maximum Intensity Projection images and scale bars were 481 generated in Fiji software (Version 1.52; National Institutes of Health). Note that the image 482 of wPip salivary glands was produced by stitching together two images taken from the same 483 sample, as the lobes spread too wide to image under a single field of view [55] . 484
Quantitative RT-PCR for immune gene targets 485
RNA was extracted from 6-day old female mosquitoes (24 per line including Rockefeller, 486 wMel, wAlbB, wPip) using the RNeasy 96 QIAcube HT kit (Qiagen). Samples were DNAseI 487 treated and cDNA was generated from 8 µL of purified RNA/individual (~500 ng of RNA) 488 using SuperScript™ III First-Strand Synthesis System (ThermoFisher). cDNA was diluted 2-489 fold with RNase-free water then expression levels of selected immune genes was determined 490 by amplifying 1 µL of cDNA with primers for cecropin D (AAEL000598; forward 5'-491 GCTAGGTCAAACCGAAGCAG, reverse 5'-TCCTACAACAACCGGGAGAG) [23] , 492 cecropin E (AAEL000611; forward 5'-TTGCACTCGTTCTGCTCATC, reverse 5'-493 ACACGTTTTCCGACTCCTTC) [23] , defensin C (AAEL003832-RA; forward 5'-494 GCTGAGTGGGTTCGGTGTAG, reverse 5'-CGCGTTACAATAGCCTCCTC) [21] , C-type 495 lectin (AAEL005641; forward 5'-GTCTCCGGGTGCAATACACT, reverse 5'-496 CCCTATCGTTCCACTTCCAA) [23] or Transferrin (AAEL0015458; forward 5'-497 TCAGGATCTGATGGCCAAAC, reverse 5'-GCCTTGACCTTCTCCAGACA) [23] . 498
Expression levels were normalized to the Ae. aegypti house-keeping gene RPS17 (forward 5'-499 TCCGTGGT ATCTCCATCAAGCT, reverse 5'-CACTTCCGGCACGTAGTTGTC) using 500 the delta CT method (2 CT (reference)/ 2 CT (target)). 501 502
Ethics statement 503
Blood feeding by volunteers (Monash University human ethics permit no CF11/0766-504 2011000387) for this study was approved by the Monash University Human Research Ethics 505 Committee (MUHREC). All adult volunteers provided informed written consent; no child 506 participants were involved in the study. 507 508 
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